Sigachi Industries Limited (SIGACHI.NS)
INR 52.6
(2.59%)
INR 52.6
(2.59%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 707.2 Million INR | 51.75% |
| 2022 | 466.02 Million INR | 53.06% |
| 2021 | 304.47 Million INR | 43.63% |
| 2020 | 211.97 Million INR | -24.09% |
| 2019 | 279.24 Million INR | 23.77% |
| 2018 | 225.61 Million INR | 41.24% |
| 2017 | 159.73 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 707.2 Million INR | 51.75% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 521.03 Million INR | 0.0% |
| 2023 Q4 | 707.2 Million INR | 0.0% |
| 2022 Q4 | 466.02 Million INR | 0.0% |
| 2022 FY | 466.02 Million INR | 53.06% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 363.03 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | 225.86 Million INR | 6.55% |
| 2021 Q4 | 304.47 Million INR | 0.0% |
| 2021 FY | 304.47 Million INR | 43.63% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 292.43 Million INR | 29.47% |
| 2020 Q4 | 211.97 Million INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 FY | 211.97 Million INR | -24.09% |
| 2019 FY | 279.24 Million INR | 23.77% |
| 2018 FY | 225.61 Million INR | 41.24% |
| 2017 FY | 159.73 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ind-Swift Limited | 640.91 Million INR | -10.343% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 50.901% |
| Sakar Healthcare Limited | 277.32 Million INR | -155.012% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.279% |
| Innova Captab Limited | 1.44 Billion INR | 50.894% |
| Divi's Laboratories Limited | 31.84 Billion INR | 97.779% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 68.966% |
| Morepen Laboratories Limited | 2.48 Billion INR | 71.552% |
| Mankind Pharma Limited | 15.53 Billion INR | 95.448% |
| Sequent Scientific Limited | 3.46 Billion INR | 79.574% |
| Wanbury Limited | 360.23 Million INR | -96.32% |
| Laurus Labs Limited | 18.45 Billion INR | 96.168% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 90.027% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 89.391% |
| Alembic Limited | 113.4 Million INR | -523.639% |
| Hikal Limited | 3.03 Billion INR | 76.715% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 95.697% |
| Neuland Laboratories Limited | 3.5 Billion INR | 79.818% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 85.927% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 97.186% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 83.354% |
| Themis Medicare Limited | 705.74 Million INR | -0.207% |
| RPG Life Sciences Limited | 1.01 Billion INR | 29.98% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 97.945% |
| Lupin Limited | 49.53 Billion INR | 98.572% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -144.669% |
| Wockhardt Limited | 6.4 Billion INR | 88.95% |
| Vaishali Pharma Limited | 3.79 Million INR | -18525.415% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 88.999% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -371.566% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 94.516% |
| FDC Limited | 3.88 Billion INR | 81.815% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.887% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -1673.338% |
| Eris Lifesciences Limited | 1.89 Billion INR | 62.588% |
| Venus Remedies Limited | 1.21 Billion INR | 41.885% |
| ZIM Laboratories Limited | 812.62 Million INR | 12.973% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 40.294% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -1593.098% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 80.52% |
| Shilpa Medicare Limited | 3.44 Billion INR | 79.497% |
| Albert David Limited | 436.12 Million INR | -62.158% |
| Ajanta Pharma Limited | 8.28 Billion INR | 91.463% |
| Hester Biosciences Limited | 755.81 Million INR | 6.431% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 69.411% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 80.339% |
| Gufic Biosciences Limited | 2 Billion INR | 64.725% |
| Windlas Biotech Limited | 621.89 Million INR | -13.719% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 35.184% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -103.949% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 42.801% |
| Granules India Limited | 13 Billion INR | 94.562% |
| Aarti Drugs Limited | 4.85 Billion INR | 85.445% |
| Bal Pharma Limited | 878.11 Million INR | 19.463% |
| Alkem Laboratories Limited | 26.61 Billion INR | 97.343% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.283% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 8.355% |
| Medicamen Biotech Limited | 593.75 Million INR | -19.108% |
| Unichem Laboratories Limited | 7.04 Billion INR | 89.964% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -138.584% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -2673.687% |
| Valiant Laboratories Limited | 100.15 Million INR | -606.12% |
| Orchid Pharma Limited | 2.64 Billion INR | 73.235% |
| Medico Remedies Limited | 163.37 Million INR | -332.881% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -576.255% |
| Ipca Laboratories Limited | 24.71 Billion INR | 97.138% |
| Brooks Laboratories Limited | 96.1 Million INR | -635.846% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -235.463% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.897% |
| NATCO Pharma Limited | 7 Billion INR | 89.904% |
| Suven Life Sciences Limited | 7.08 Million INR | -9881.75% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -621.905% |
| Strides Pharma Science Limited | 11.26 Billion INR | 93.721% |
| Indoco Remedies Limited | 3.53 Billion INR | 79.969% |
| Alpa Laboratories Limited | 136.65 Million INR | -417.52% |
| Lasa Supergenerics Limited | 190.43 Million INR | -271.366% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -4681.01% |